Global Biosurgery Market to reach USD 17.1 billion by 2027.Global Biosurgery Market is valued at approximately USD 11.5 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.7 % over the forecast period 2021-2027. The market for biosurgery solutions is being driven by a growing focus on effective blood loss management and an increase in the number of elective surgeries. Globally, a growth in elective surgical procedures can be ascribed to the prevalence of lifestyle problems and chronic diseases, as well as a growing geriatric population. The rising frequency of accidents around the world has resulted in an increase in the number of procedures requiring extensive operating hours. As a result, the demand for appropriate blood loss management products during surgical procedures has skyrocketed. According to a 2019 article published in the National Library of Medicine, uncontrolled bleeding is the greatest cause of injury-related death. Similarly, according to the National Trauma Institute. Hemorrhage is also responsible for over 35 percent of pre-hospital mortality and over 40 percent of deaths within the first 24 hours after a traumatic injury. The number of surgeries that take a long time to complete is on the rise. There is an increasing demand for appropriate blood loss management products in such a situation. Various biosurgery products, such as hemostatic agents and surgical sealants, are increasingly being used as alternatives for traditional suture and staples during surgeries to control bleeding and cover the wound when using traditional goods is difficult or insufficient. Thus, the use of biosurgery products in efficiently reducing blood loss is driving the growth of the biosurgery market, owing to its increased adoption over conventional goods. However, high price of biosurgery products and the rising cost of surgical procedures may impede market growth over the forecast period of 2021-2027.

The regional analysis of the global Biosurgery Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World (ROW). North America is the leading region across the world in terms of market share due to presence of a highly developed healthcare system in the region. Whereas Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to the rising prevalence of traumatic injuries and lifestyle disorders.

Major market player included in this report are:

Johnson & Johnson
Baxter International Inc.
Medtronic Plc
Dickinson & Co.
B. Braun Melsungen AG
Stryker Corp.
Integra Lifesciences Holdings Corp.
Hemostasis LLC.
Pfizer Inc.
Zimmer Biomet
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Bone Graft Substitutes
Soft-tissue attachments
Hemostatic agents
Surgical sealants and adhesives
Others
By Application:
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Others
By End user:
Hospitals
Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018-19
Base year - 2019-2020
Forecast period - 2021 to 2027.

Target Audience of the Global Biosurgery Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors